Global Strategic BD Leader in Life Sciences

TSP, a Syneos Health company; City of Edinburgh; On-site; GBP 140,000 - 200,000; Full time

Job summary

Syneos Health is seeking an Executive Director, Business Development (Strategic Accounts) to drive enterprise-level sales growth through global account strategy and long-term client engagement.

In this role, you will navigate procurement environments, negotiate MSAs, and lead cross-functional solution development with clinical, legal, finance, and delivery teams to deliver client-centric growth for major biopharma partnerships.

Qualifications

• Bachelor's degree in a science-related field; graduate degree preferred.
• Significant experience in strategic sales and global business development.
• Deep knowledge of the pharmaceutical landscape and clinical trials.

Responsibilities

• Leads global business development across high-value accounts to drive strategic growth.
• Identifies and pursues enterprise-level opportunities, MSAs and strategic alliances.
• Develops multi-year strategic growth plans for key global clients.
• Acts as strategic advisor to client executives and negotiates master service agreements.
• Collaborates with cross-functional teams to craft client-tailored solutions.
• Maintains CRM records, including contacts, opportunities, and communications.

Skills

Strategic sales

Global business development

Client relationship management

Pharma industry knowledge

Negotiation

Cross-functional collaboration

CRM (Salesforce)

Communication skills

Education

Bachelor's degree in science

Graduate degree preferred

Tools

Salesforce

MS Office

Google Workspace

Job description

Syneos Health is seeking an Executive Director, Business Development (Strategic Accounts) to drive enterprise-level sales growth through global account strategy and long-term client engagement.

In this role, you will navigate procurement environments, negotiate MSAs, and lead cross-functional solution development with clinical, legal, finance, and delivery teams to deliver client-centric growth for major biopharma partnerships.